Recent Publications
Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.
Ellis RJ, Pugh SL, Yu JB, Feng FY, Konski AA, Grubb RL 3rd, Wallace RE, Gladstone DJ, Menard C, Miccio JA, Frazier AJ, Pennington JD, Michalski JM, Spratt DE, Martinez A, Morgan SC, Mihai A, Solanki AA, Amjad A, Straza MW, Delouya G, Schroeder TM, Marshall DT, Kapadia N, Patel AN, Cescon TP, El-Gayed A, Yoon HA, Paulus R, Sandler HM, NRG-GU005 Collaborative Authors
JAMA. 2026 Aug 13; doi: 10.1001/jama.2026.12627. Epub 2026 Aug 13.
PMID: 42593775
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.
Kinslow CJ, Minniti G, Brown PD, Vogelbaum MA, Ballman KV, Mercurio A, Siegelin MD, Kocakavuk E, Tuohy K, Mansouri A, Touat M, Ducray F, Dehais C, Dipasquale A, Simonelli M, DeStephano DM, Grinband J, Yu JB, Walch H, Parker MI, Shuryak I, Roy S, Hervey-Jumper SL, Gallitto M, Horowitz DP, McKhann GM, Sisti MB, Bruce JN, Canoll P, Ostrom QT, Neugut AI, Pike LRG, Iwamoto FM, Cheng SK, Kachnic LA, Mehta MP, Wang TJC
J Clin Oncol. 2026 Aug 12;:JCO2501846. doi: 10.1200/JCO-25-01846. Epub 2026 Aug 12.
PMID: 42585601
Diversity, equity, and inclusion as scientific rigor: progress during challenging times.
Nogueira LM, Hudson MF, Pistilli B, Hochster H, Ambs S, Stockler MR, Yu JB, Franco EL
J Natl Cancer Inst. 2026 Jul 1;118(7):1131-1134. doi: 10.1093/jnci/djag066.
PMID: 42257610
Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer.
Leapman MS, Rothen J, Long JB, Kim IE, Mitchell AP, Yu JB, Dinan MA, Gross CP, Ma X
JAMA Oncol. 2026 Jul 1;12(7):785-787. doi: 10.1001/jamaoncol.2026.0893.
PMID: 42096231
Diversity, equity, and inclusion as scientific rigor: progress during challenging times.
Nogueira LM, Hudson MF, Pistilli B, Hochster H, Ambs S, Stockler MR, Yu JB, Franco EL
JNCI Cancer Spectr. 2026 May 9;10(3) doi: 10.1093/jncics/pkag046.
PMID: 42257977
County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care.
Gaddy JJ, Lee DH, Herrin J, Yu JB, Pollack CE, Dean LT, Dougherty GB, Canavan ME, Soulos PR, Gross CP
JAMA Netw Open. 2026 May 1;9(5):e2613919. doi: 10.1001/jamanetworkopen.2026.13919. Epub 2026 May 1.
PMID: 42160049
In Reply to Shaffer et al.
Yu JB, Grew D, Spraker MB, Beckta JM, Shah C, Brower JV
Pract Radiat Oncol. 2026 May-Jun;16(3):320. doi: 10.1016/j.prro.2025.10.016.
PMID: 42103411
Factors Associated With Rectal Spacer Use in Prostate Cancer Patients Receiving Radiation Therapy.
Hankins RA, Morris KC, McGovern AM, Zack J, Collins SP, Yu JB
Cancer Med. 2026 May;15(5):e71765. doi: 10.1002/cam4.71765.
PMID: 42046879
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic Therapy.
Einstein DJ, Chen RC, Hoffman KE, Madan RA, Marvaso G, Tang C, Tran PT, Yu JB, Regan MM
Int J Radiat Oncol Biol Phys. 2026 May 1;125(1):40-43. doi: 10.1016/j.ijrobp.2025.11.006.
PMID: 42000365
The Comparative Toxicity of Focal Ablation Versus Intensity Modulated Radiation Therapy for Prostate Cancer.
Yu JB, DeStephano DM, Jeffers B, Tward AE, Spina CS, Horowitz DP, Wang TJC, Kachnic LA, Soulos PR, Gross CP, Cheng SK
Int J Radiat Oncol Biol Phys. 2026 Mar 15;124(4):937-948. doi: 10.1016/j.ijrobp.2025.09.020. Epub 2025 Sep 23.
PMID: 40998272